New agent to treat advanced or metastasized thyroid cancer, its efficacy, safety, and mechanism.

Vandetanib is the first US Food and Drug Administration approved agent to treat advanced or metastasized thyroid cancer. To gain a better understanding of the drug, we conducted a systematic review of its efficacy and safety in patients with thyroid cancers.